跳轉至內容
Merck
  • Role of complement components in vasculitic neuropathy associated with systemic lupus erythematosus and rheumatoid arthritis.

Role of complement components in vasculitic neuropathy associated with systemic lupus erythematosus and rheumatoid arthritis.

Muscle & nerve (2022-05-19)
Yuki Fukami, Haruki Koike, Masahiro Iijima, Naohiro Mouri, Ryoji Nishi, Masahisa Katsuno
摘要

The mechanism of complement-mediated neurological injury in vasculitic neuropathy associated with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) is unknown. The current study aimed to investigate the local activation of the complement system in vasculitic neuropathy associated with SLE and RA. We analyzed sural nerve biopsy specimens collected from patients with SLE (n = 12) and RA (n = 12). The deposition of complement components comprising the classical and lectin pathways was assessed via immunohistochemistry. The disease duration was longer in the RA group than in the SLE group (median [interquartile range]: 11.5 [5.5-31.0] and 4 [2-10] y, respectively). Complement components were found in the epineurial blood vessel walls in patients with SLE and RA, but not in controls. Deposition of the classical pathway component C1q in the blood vessel wall was more commonly observed in the SLE group (71.3% [25.6-85.8]) than in the RA group (20.1% [10.5-35.6]). As for the lectin pathway component, the incidence of ficolin-3 deposition in the blood vessel wall was higher in the SLE group (42.3% [25.7-51.3]) than in the RA group (17.2% [10.3-26.8]). On the contrary, the mannose-binding lectin level was higher in the RA group (37.5% [21.7-51.4]) than in the SLE group (17.8% [11.4-31.0]). The classical and lectin pathways of the complement system may be involved in vasculitic neuropathy associated with SLE and RA.